Mid-Term Outcome of Mitral Valve Repair and Coronary Artery Bypass Grafting for Ischemic or Degenerative Mitral Regurgitation

Aim of the study. To verify the impact of the etiology of mitral valve regurgitation on a 5-year outcome after repair and concomitant coronary artery bypass grafting (CABG). Methods. One hundred and eleven consecutive patients (mean age of 69+/-8 years) who underwent mitral valve repair, 65 for isch...

Full description

Bibliographic Details
Main Authors: Paolo Nardi, Antonio Pellegrino, Carlo Bassano, Fabio Bertoldo, Antonio Scafuri, Jacob Zeitani, Luigi Chiariello
Format: Article
Language:English
Published: GESDAV 2012-06-01
Series:Archives of Clinical and Experimental Surgery
Subjects:
Online Access:http://www.scopemed.org/fulltextpdf.php?mno=17247
id doaj-4b94a228ed9644aea9e279aad895acde
record_format Article
spelling doaj-4b94a228ed9644aea9e279aad895acde2020-11-24T22:52:08ZengGESDAVArchives of Clinical and Experimental Surgery2146-81332012-06-011312913710.5455/aces.2012041202584017247Mid-Term Outcome of Mitral Valve Repair and Coronary Artery Bypass Grafting for Ischemic or Degenerative Mitral RegurgitationPaolo Nardi0Antonio Pellegrino1Carlo Bassano2Fabio Bertoldo3Antonio Scafuri4Jacob Zeitani5Luigi ChiarielloCardiac Surgery Unit, Tor Vergata University of Rome, Policlinico Tor Vergata, Rome, Italy Cardiac Surgery Unit, Tor Vergata University of Rome, Policlinico Tor Vergata, Rome, Italy Cardiac Surgery Unit, Tor Vergata University of Rome, Policlinico Tor Vergata, Rome, Italy Cardiac Surgery Unit, Tor Vergata University of Rome, Policlinico Tor Vergata, Rome, Italy Cardiac Surgery Unit, Tor Vergata University of Rome, Policlinico Tor Vergata, Rome, Italy Cardiac Surgery Unit, Tor Vergata University of Rome, Policlinico Tor Vergata, Rome, ItalyAim of the study. To verify the impact of the etiology of mitral valve regurgitation on a 5-year outcome after repair and concomitant coronary artery bypass grafting (CABG). Methods. One hundred and eleven consecutive patients (mean age of 69+/-8 years) who underwent mitral valve repair, 65 for ischemic and 46 for degenerative mitral regurgitation, and concomitant CABG, were retrospectively analyzed. The mean follow-up was 40+/-28 (9-104) months. Five-year survival (including operative mortality), and survival free from events (postoperative low output syndrome, progression of mitral regurgitation, onset or worsening of congestive heart failure, recurrence of myocardial infarction, and the need for mitral valve replacement) were analyzed. Results. Compared with degenerative, ischemic mitral regurgitation was associated with a higher incidence of previous myocardial infarction (P<0.0001), left ventricular ejection fraction (LVEF) <0.45 (P<0.0001), and more diseased coronary vessels per patient (P<0.0001). Five-year all-cause mortality was 18% (20/111). Independent predictors of mortality were older age at operation (P=0.0008), LVEF<0.45 (P=0.04), and the ischemic etiology of mitral regurgitation (P=0.03). At five years, survival was 69%+/-7.6% for ischemic versus 87%+/-6.5% for degenerative etiology (P=0.03); event-free survival was 58%+/-8.4% versus 75%+/-8% (P=0.02), and freedom from late cardiac death was 85%+/-6.6% versus 100% (P=0.02). Freedom from mitral valve reoperation was 97+/-2.4%. Conclusions. Ischemic mitral regurgitation and ldquo;per se and rdquo; predicted limited survival and event-free survival. Left ventricular dysfunction is frequently associated with the ischemic etiology. An early surgical indication to prevent left ventricular dysfunction could be important to improve the mid-term outcome. [Arch Clin Exp Surg 2012; 1(3.000): 129-137]http://www.scopemed.org/fulltextpdf.php?mno=17247Mitral valve repairdegenerative mitral valve diseaseischemic mitral valve diseasecoronary artery bypass grafting surgery
collection DOAJ
language English
format Article
sources DOAJ
author Paolo Nardi
Antonio Pellegrino
Carlo Bassano
Fabio Bertoldo
Antonio Scafuri
Jacob Zeitani
Luigi Chiariello
spellingShingle Paolo Nardi
Antonio Pellegrino
Carlo Bassano
Fabio Bertoldo
Antonio Scafuri
Jacob Zeitani
Luigi Chiariello
Mid-Term Outcome of Mitral Valve Repair and Coronary Artery Bypass Grafting for Ischemic or Degenerative Mitral Regurgitation
Archives of Clinical and Experimental Surgery
Mitral valve repair
degenerative mitral valve disease
ischemic mitral valve disease
coronary artery bypass grafting surgery
author_facet Paolo Nardi
Antonio Pellegrino
Carlo Bassano
Fabio Bertoldo
Antonio Scafuri
Jacob Zeitani
Luigi Chiariello
author_sort Paolo Nardi
title Mid-Term Outcome of Mitral Valve Repair and Coronary Artery Bypass Grafting for Ischemic or Degenerative Mitral Regurgitation
title_short Mid-Term Outcome of Mitral Valve Repair and Coronary Artery Bypass Grafting for Ischemic or Degenerative Mitral Regurgitation
title_full Mid-Term Outcome of Mitral Valve Repair and Coronary Artery Bypass Grafting for Ischemic or Degenerative Mitral Regurgitation
title_fullStr Mid-Term Outcome of Mitral Valve Repair and Coronary Artery Bypass Grafting for Ischemic or Degenerative Mitral Regurgitation
title_full_unstemmed Mid-Term Outcome of Mitral Valve Repair and Coronary Artery Bypass Grafting for Ischemic or Degenerative Mitral Regurgitation
title_sort mid-term outcome of mitral valve repair and coronary artery bypass grafting for ischemic or degenerative mitral regurgitation
publisher GESDAV
series Archives of Clinical and Experimental Surgery
issn 2146-8133
publishDate 2012-06-01
description Aim of the study. To verify the impact of the etiology of mitral valve regurgitation on a 5-year outcome after repair and concomitant coronary artery bypass grafting (CABG). Methods. One hundred and eleven consecutive patients (mean age of 69+/-8 years) who underwent mitral valve repair, 65 for ischemic and 46 for degenerative mitral regurgitation, and concomitant CABG, were retrospectively analyzed. The mean follow-up was 40+/-28 (9-104) months. Five-year survival (including operative mortality), and survival free from events (postoperative low output syndrome, progression of mitral regurgitation, onset or worsening of congestive heart failure, recurrence of myocardial infarction, and the need for mitral valve replacement) were analyzed. Results. Compared with degenerative, ischemic mitral regurgitation was associated with a higher incidence of previous myocardial infarction (P<0.0001), left ventricular ejection fraction (LVEF) <0.45 (P<0.0001), and more diseased coronary vessels per patient (P<0.0001). Five-year all-cause mortality was 18% (20/111). Independent predictors of mortality were older age at operation (P=0.0008), LVEF<0.45 (P=0.04), and the ischemic etiology of mitral regurgitation (P=0.03). At five years, survival was 69%+/-7.6% for ischemic versus 87%+/-6.5% for degenerative etiology (P=0.03); event-free survival was 58%+/-8.4% versus 75%+/-8% (P=0.02), and freedom from late cardiac death was 85%+/-6.6% versus 100% (P=0.02). Freedom from mitral valve reoperation was 97+/-2.4%. Conclusions. Ischemic mitral regurgitation and ldquo;per se and rdquo; predicted limited survival and event-free survival. Left ventricular dysfunction is frequently associated with the ischemic etiology. An early surgical indication to prevent left ventricular dysfunction could be important to improve the mid-term outcome. [Arch Clin Exp Surg 2012; 1(3.000): 129-137]
topic Mitral valve repair
degenerative mitral valve disease
ischemic mitral valve disease
coronary artery bypass grafting surgery
url http://www.scopemed.org/fulltextpdf.php?mno=17247
work_keys_str_mv AT paolonardi midtermoutcomeofmitralvalverepairandcoronaryarterybypassgraftingforischemicordegenerativemitralregurgitation
AT antoniopellegrino midtermoutcomeofmitralvalverepairandcoronaryarterybypassgraftingforischemicordegenerativemitralregurgitation
AT carlobassano midtermoutcomeofmitralvalverepairandcoronaryarterybypassgraftingforischemicordegenerativemitralregurgitation
AT fabiobertoldo midtermoutcomeofmitralvalverepairandcoronaryarterybypassgraftingforischemicordegenerativemitralregurgitation
AT antonioscafuri midtermoutcomeofmitralvalverepairandcoronaryarterybypassgraftingforischemicordegenerativemitralregurgitation
AT jacobzeitani midtermoutcomeofmitralvalverepairandcoronaryarterybypassgraftingforischemicordegenerativemitralregurgitation
AT luigichiariello midtermoutcomeofmitralvalverepairandcoronaryarterybypassgraftingforischemicordegenerativemitralregurgitation
_version_ 1725666985466920960